What changes on September 8—and what does not
The July 16 CMS memorandum changes one survey procedure from September 8, 2026: state agencies may use a risk-based Long-Term Care Survey Process for eligible nursing homes. It remains the standard recertification survey and does not replace complaint surveys. The procedural differences are a smaller resident sample, fewer surveyors and activities, and about half the survey time; every required area still receives a streamlined review.
CMS gives a capacity rationale for the change. Complaint work has increased, while the federal survey budget has remained flat since 2015. CMS also says its pilot in 22 states and more than 100 facilities produced findings comparable to the traditional process. That is the agency's reported pilot conclusion, not published evidence that the shorter procedure will detect every kind of defect at the same rate.
A five-star rating is only the first gate
A five-star overall rating does not establish eligibility by itself. CMS expects roughly 12% of nursing homes to qualify initially, using 11 criteria that also address staffing rating, serious citations, staffing and MDS audits, health-inspection performance, certain schizophrenia coding, elapsed time since the last standard survey, ownership change, staffing waivers, and Special Focus Facility candidate status.
Eligibility is both time-limited and reviewable. CMS will issue quarterly lists to states, and a listed facility qualifies for six months unless a disqualifying event intervenes. Complaints or other resident-safety concerns may still cause a state or CMS to use the traditional process, and the requirement for a standard survey at least every 15 months remains. CMS plans a Care Compare icon for September 30, but that public display may lag the state's working list; neither the icon nor the list is a compliance certificate or safe harbor.
The F756 chain did not get shorter
Nothing in the survey memorandum amends the pharmacy-services rule or Appendix PP. The underlying requirement in 42 CFR § 483.45(c) remains a licensed-pharmacist review of each resident's drug regimen at least monthly, including the medical chart. When that review identifies an irregularity, a separate written report must go to the attending physician, medical director, and director of nursing and identify at least the resident, drug, and irregularity.
The response requirements also remain separate from survey procedure. The attending physician documents review and action, with rationale in the record when the medication is unchanged; facility policy sets time frames and the pharmacist's urgent-action path. Appendix PP expects a signed and dated statement when the pharmacist finds no irregularity. Software may organize those records, but a ‘sent’ or ‘closed’ label does not establish receipt, action, rationale, or follow-up.
Draw one proportionate recordkeeping implication
The memo contains no new pharmacy-documentation standard tied to sample size. A narrower implication follows from the procedure: if a resident is selected, the existing trail should be understandable without reconstructing it from oral history, an inbox, a shared drive, the pharmacy system, and the facility chart.
A reconstructable trail keeps the resident context and specific irregularity with the recipients, report date and route, response, rationale, present status, and next review point. That is not a call for more indiscriminate documentation; it is a call for a concise record whose required links remain visible.
Run a six-link record test before September
Use three existing examples: an ordinary recommendation, an urgent irregularity, and an item closed without a medication change. Ask a colleague who did not handle them to follow only the records they are permitted to see. Each avoidable clarification request exposes a link to repair prospectively; it is not permission to backfill an undocumented fact.
One uncertainty remains explicit: CMS had not made the RBS Procedure Guide public with the July memorandum. Pharmacy-specific mechanics therefore should not be inferred. The six-link exercise neither certifies compliance nor predicts a survey result; it only tests whether the routine record can stand on its own for a reviewer or covering consultant.
- Context: From the permitted record, identify the chart, medication, indication, monitoring information, and resident circumstances available to the pharmacist.
- Finding: Confirm that the irregularity or clinical question is dated, specific to the resident, and not merely generic template language.
- Route: Locate the required recipients and delivery method, while keeping attempted delivery separate from verified delivery.
- Response: Find the physician's documented action or, when the medication stayed unchanged, the documented rationale in the appropriate record.
- Follow-up: Check that an unresolved, deferred, or time-bound item remains visible to both the assigned consultant and a covering pharmacist.
- Correction: Compare any changed report or status with the original and identify the correction, author, and date.